Procognia collaborates with a Sweedish comp - Uni Targeting Research for the development of biosimilar and biobetter drugs. Today they published (only in Hebrew for now) preclinical results about their version of Humira.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.